
- Sol-Gel Technologies (SLGL) is a clinical-stage dermatology company focused on topical drugs for skin diseases.
- SLGL demonstrates exceptional technical momentum and is up 1,310% over the past 52 weeks.
- The stock set a new three-year high earlier in March.
- Despite strong price action, SLGL remains highly speculative and unproven.